New Artificial Intelligence (AI) applications in healthcare will lead to billions in savings within the sector over the next four years announced ABI Research, a market-foresight advisory firm providing strategic guidance on the most compelling transformative technologies.
In its recent report, ABI Research finds that while only a few AI applications have resulted in commercialized and scaled solutions so far, most do show promise in Proof of Concepts (PoCs). If successful, these applications could produce more effective drugs, save doctors’ time, and save lives.
Hospitals in Israel and the United States have already started to adopt AI-based predictive analytics. The number of patient monitoring devices using the data to train AI models for predictive analytics will rise from 53,000 at the end of 2017 to 3.1 million in 2021 with a CAGR of 176%. This includes the use of AI for home-based preventive healthcare solutions. With more devices connected to AI-based predictive analytics models, hospitals will save US$52 billion in 2021, led by North America with US$21 billion in savings.
“If AI vendors hope to fulfill the potential of their applications in hospitals and medical institutions, they must help implement the communications, network, and IT infrastructure necessary to deliver actionable analytics,” says Pierce Owen, Principal Analyst at ABI Research. “Unfortunately, clinicians in most hospitals often must work with pen and paper or pagers from twenty years ago and have limited access to secure, networked devices. These institutions need help to collect data in a secure manner and deliver actionable analytics while staying compliant with all regulations.”
Applications that target hospitals and medical institutions include predictive analytics for patient monitoring, finding patients for clinical trials and transcribing notes for electronic health records (EHRs). EarlySense builds AI-based predictive analytics that use data from a contact-free sensor that goes underneath a mattress. The company has launched products for both hospitals and homes. Deep 6 AI finds and matches patients to clinical trials. It claims it shortens the process from ten months to seven minutes. It scans complete EMRs including the free text and reports using natural language processing (NLP) to find the best possible matches. Cedars-Sinai Medical Center in Los Angeles has used Deep 6 and already sees an ROI of US$10,500 per trial. LexiconAI has expanded its NLP voice-controlled transcription software to healthcare to save clinicians time in filling out EHRs. Its PoCs have resulted in US$5,000 per user per year in efficiency and savings, and it only takes early adopters one month to reach ROI.
Of course, not all the applications examined within the report target hospitals. Pharmaceutical companies continue to invest in AI for drug discovery, and some AI vendors target patients for pre-primary care. AI has yet to generate a molecule design for a drug that has gone to market but some from BERG Health have made it into Phase I and Phase II trials with successful results so far. AI-based pre-primary care apps with NLP, such as Your.MD, have already gone to market.
With human lives potentially at stake, AI vendors also need to establish a reputation of trust through PoCs and proper regulatory approval before attempting to scale. Once scaled, they may need to assist with data curation through managed services for clients that lack data scientists.
“We as a society need AI to transform the healthcare sector across the board. Already, people without insurance cannot afford care, and the massive increases in costs and healthcare spending will become a drag and burden on the economy if they continue. Luckily, a couple of these AI applications have already proven they can save money and lives,” concludes Owen.
These findings are from ABI Research’s Artificial Intelligence in Smart Healthcare report. This report is part of the company’s AI & Machine Learning research service which includes research, data, and Executive Foresights.
About ABI Research
ABI Research provides strategic guidance for visionaries needing market foresight on the most compelling transformative technologies, which reshape workforces, identify holes in a market, create new business models and drive new revenue streams. ABI’s own research visionaries take stances early on those technologies, publishing groundbreaking studies often years ahead of other technology advisory firms. ABI analysts deliver their conclusions and recommendations in easily and quickly absorbed formats to ensure proper context. Our analysts strategically guide visionaries to take action now and inspire their business to realize a bigger picture. For more information about ABI Research’s forecasting, consulting and teardown services, visionaries can contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific or visit www.abiresearch.com.
About ABI Research
ABI Research is a global technology intelligence firm delivering actionable research and strategic guidance to technology leaders, innovators, and decision makers around the world. Our research focuses on the transformative technologies that are dramatically reshaping industries, economies, and workforces today.
ABI Research提供开创性的研究和战略指导，帮助客户了解日新月异的技术。 自1990年以来，我们已与全球数百个领先的技术品牌，尖端公司，具有远见的政府机构以及创新的贸易团体建立了合作关系。 我们帮助客户创造真实的业务成果。
For more information about ABI Research’s services, contact us at +1.516.624.2500 in the Americas, +44.203.326.0140 in Europe, +65.6592.0290 in Asia-Pacific, or visit www.abiresearch.com.
Asia: +65 6950.5670